Rhino-Cerebral Mucormycosis with Otologic Involvement

Monalisa Jati1, Ruuzeno Koutsu1, Nitin M Nagarkar1

  • 1Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh 492099 India.

Insights

Mucormycosis, a fungal infection, can affect the ear in COVID-19 patients. Early evaluation of otologic involvement is crucial, even without symptoms, in post-COVID mucormycosis cases.

Area of Science:

  • Infectious Diseases
  • Otolaryngology
  • Mycology

Background:

  • Mucormycosis is an opportunistic invasive fungal infection.
  • Recent cases link mucormycosis to COVID-19, often due to underlying health conditions.
  • Otologic (ear) involvement is an uncommon but significant complication.

Purpose of the Study:

  • To highlight the importance of evaluating otologic involvement in patients with post-COVID mucormycosis.
  • To emphasize that ear involvement may occur even without apparent clinical signs or symptoms.
  • To underscore the need for vigilance in diagnosing and managing this condition.

Main Methods:

  • This report is based on clinical observations and literature review concerning mucormycosis in COVID-19 patients.
  • It focuses on cases with otologic manifestations.
  • The study emphasizes the diagnostic considerations for ear involvement.

Main Results:

  • Otologic involvement in post-COVID mucormycosis, while exceptional, is a critical aspect to consider.
  • Absence of overt clinical signs does not rule out otologic disease.
  • Early detection and intervention are vital for patient outcomes.

Conclusions:

  • Healthcare providers should actively assess for otologic complications in all patients diagnosed with post-COVID mucormycosis.
  • Prompt recognition and management of ear involvement can prevent severe sequelae.
  • This underscores the multifaceted nature of opportunistic infections in immunocompromised individuals.